As of 2025-12-31, the EV/EBITDA ratio of Moderna Inc (MRNA) is -3.70. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNA's latest enterprise value is 10,805.58 mil USD. MRNA's TTM EBITDA according to its financial statements is -2,920.00 mil USD. Dividing these 2 quantities gives us the above MRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 12.6x | 11.3x |
| Forward P/E multiples | 10.8x - 13.7x | 12.3x |
| Fair Price | (78.12) - (91.57) | (85.44) |
| Upside | -356.9% - -401.1% | -381.0% |
| Date | EV/EBITDA |
| 2025-12-30 | -3.70 |
| 2025-12-29 | -3.80 |
| 2025-12-26 | -3.81 |
| 2025-12-24 | -4.01 |
| 2025-12-23 | -3.95 |
| 2025-12-22 | -4.30 |
| 2025-12-19 | -4.15 |
| 2025-12-18 | -3.77 |
| 2025-12-17 | -3.71 |
| 2025-12-16 | -3.63 |
| 2025-12-15 | -3.63 |
| 2025-12-12 | -3.57 |
| 2025-12-11 | -3.60 |
| 2025-12-10 | -3.52 |
| 2025-12-09 | -3.41 |
| 2025-12-08 | -3.37 |
| 2025-12-05 | -3.34 |
| 2025-12-04 | -3.04 |
| 2025-12-03 | -3.00 |
| 2025-12-02 | -2.85 |
| 2025-12-01 | -2.86 |
| 2025-11-28 | -3.11 |
| 2025-11-26 | -2.98 |
| 2025-11-25 | -2.94 |
| 2025-11-24 | -2.86 |
| 2025-11-21 | -2.81 |
| 2025-11-20 | -2.62 |
| 2025-11-19 | -2.87 |
| 2025-11-18 | -2.97 |
| 2025-11-17 | -2.94 |
| 2025-11-14 | -2.95 |
| 2025-11-13 | -2.97 |
| 2025-11-12 | -3.21 |
| 2025-11-11 | -3.17 |
| 2025-11-10 | -2.94 |
| 2025-11-07 | -2.92 |
| 2025-11-06 | -2.89 |
| 2025-11-05 | -2.78 |
| 2025-11-04 | -2.81 |
| 2025-11-03 | -2.96 |
| 2025-10-31 | -3.27 |
| 2025-10-30 | -3.40 |
| 2025-10-29 | -2.94 |
| 2025-10-28 | -3.02 |
| 2025-10-27 | -3.20 |
| 2025-10-24 | -3.21 |
| 2025-10-23 | -3.14 |
| 2025-10-22 | -3.22 |
| 2025-10-21 | -3.31 |
| 2025-10-20 | -3.28 |